Therapeutic framework nucleic acid complexes targeting oxidative stress and pyroptosis for the treatment of

Jiafeng Li1, Yifan Li1, Xiushuai Shang1

  • 1Department of Orthopedics, The First Affiliated Hospital, Zhejiang University School of Medicine, No. 79 Qingchun Road, Hangzhou, China.

Materials Today. Bio
|September 16, 2024
PubMed

Insights

This study introduces a new treatment for osteoarthritis (OA) using nobiletin delivered by tetrahedral framework nucleic acid complexes (TNCs). TNCs effectively reduce oxidative stress and pyroptosis, protecting cartilage and alleviating OA symptoms.

Area of Science:

  • Biomedical Engineering
  • Molecular Biology
  • Orthopedics

Background:

  • Osteoarthritis (OA) is a prevalent degenerative joint disease with no effective treatments.
  • Oxidative stress and pyroptosis are key contributors to OA pathogenesis.
  • Current therapeutic strategies for OA are limited.

Purpose of the Study:

  • To develop a novel therapeutic approach for OA targeting oxidative stress and pyroptosis.
  • To evaluate the efficacy of nobiletin delivered by tetrahedral framework nucleic acid complexes (TNCs) for OA treatment.

Main Methods:

  • Synthesis of tetrahedral framework nucleic acid (tFNAs) to form TNCs for nobiletin (Nob) delivery.
  • In vitro and in vivo studies to assess TNC's bioavailability, stability, biosafety, and therapeutic effects.
  • Analysis of chondrocyte oxidative stress, pyroptosis, and extracellular matrix metabolism.

Main Results:

  • TNC demonstrated favorable bioavailability, stability, and biosafety for nobiletin delivery.
  • TNC treatment significantly alleviated OA symptoms and protected articular cartilage in vitro and in vivo.
  • TNC effectively eliminated oxidative stress, inhibited pyroptosis, and restored chondrocyte anabolic metabolism.

Conclusions:

  • TNC represents a promising therapeutic strategy for osteoarthritis by targeting oxidative stress and pyroptosis.
  • This novel approach holds potential for treating OA and cartilage injury.
  • Further research into TNC-mediated drug delivery for joint diseases is warranted.

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
12.2K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.4K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K